%0 Journal Article
%T Investigation Correlates of Chlamydia Anti-Body Testing and Hysterosalpingography among Women with Tubal Infertility
%A Afolabi Korede Koledade
%A Adebiyi Gbadebo Adesiyun
%J Open Journal of Obstetrics and Gynecology
%P 1077-1081
%@ 2160-8806
%D 2014
%I Scientific Research Publishing
%R 10.4236/ojog.2014.416148
%X <p class=\"MsoNormal\">
	<span lang=\"EN-US\" style=\"font-family:Verdana, sans-serif;\">Background:<span class=\"apple-converted-space\">&nbsp;</span></span><i>Chlamydia
trachomatis</i><span class=\"apple-converted-space\"></span><span lang=\"EN-US\" style=\"font-family:Verdana, sans-serif;\"><span \"=\"\"><span \"=\"\">&nbsp;</span></span><span lang=\"EN-US\" style=\"font-family:Verdana, sans-serif;\">infection is an important preventable cause of infertility. In
women, up to 70% of genital infection with<span class=\"apple-converted-space\">&nbsp;</span></span></span><i><span lang=\"EN-US\" style=\"font-family:Verdana, sans-serif;\">Chlamydia trachomatis</span></i><span class=\"apple-converted-space\"></span><span lang=\"EN-US\" style=\"font-family:Verdana, sans-serif;\"><span \"=\"\"><span \"=\"\">&nbsp;</span></span><span lang=\"EN-US\" style=\"font-family:Verdana, sans-serif;\">are
asymptomatic. In the management of infertility patients, a lot of clinicians or
centres do not routinely screen for<span class=\"apple-converted-space\">&nbsp;</span></span></span><i><span lang=\"EN-US\" style=\"font-family:Verdana, sans-serif;\">Chlamydia trachomatis</span></i><span class=\"apple-converted-space\"></span><span lang=\"EN-US\" style=\"font-family:Verdana, sans-serif;\"><span \"=\"\"><span \"=\"\">&nbsp;</span></span><span lang=\"EN-US\" style=\"font-family:Verdana, sans-serif;\">infection.
Hence all patients being investigated for infertility may potentially be at
risk of tubal blockage in addition to non-tubal factor aetiology. Those with
primary tubal blockage also are at risk of worsening of the blockage.
Objective: To determine if there is a relationship between IgG and IgM
Chlamydia antibody testing (CAT) and tubal factor infertility. Design: It was a
cross sectional descriptive study. Method: The sera of 400 consecutive
consenting infertile patients presenting to the gynaecological clinic of the
Ahmadu Bello University Teaching Hospital, Zaria, Northern Nigeria were tested
for Chlamydia antibodies using ELISA IgG and IgM kits produced by Diagnostic
Automation, Inc., 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302, USA. Results:
Up to 264 (66%) of the patients had tubal factor, 64 (16%) had uterine, 56
(14%) had ovarian, 50 (12.5%) had male while 40 (10%) had others. The causative
factors were not mutually exclusive. The sero-prevalence of IgG and IgM</span></span><i><span lang=\"EN-US\" style=\"font-family:Verdana, sans-serif;\">Chlamydia trachomatis</span></i><span class=\"apple-converted-space\"></span><span lang=\"EN-US\"
%K Sero-Prevalence
%K &lt
%K i&gt
%K Chlamydia trachomatis&lt
%K /i&gt
%K IgG Antibodies
%K IgM Antibodies
%K Tubal Infertility
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=52518